Which Companies Lead the Ginger and Jujube Cold-removing Granules Market in 2026?

Ginger and Jujube Cold-removing Granules by Application (Hospital, Clinic, Other), by Types (10g Per Bag, 15g Per Bag), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $46.2 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 148

Forecast Period: 2026 - 2033

Market Size: $46.2 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ginger and Jujube Cold-removing Granules Market Overview

Ginger and Jujube Cold‑removing Granules are herbal formulations primarily used in Traditional Chinese Medicine to alleviate cold symptoms, fever, and fatigue. Their relevance has surged as consumers seek natural, fast‑acting remedies for seasonal colds. The Ginger and Jujube Cold‑removing Granules market size reached approximately USD 120 million in 2025, and industry analysts project a robust growth outlook with a CAGR of 6.5% for the market forecast 2026‑2033. This expansion is driven by rising incidences of respiratory infections, growing health‑consciousness, supportive government policies for herbal products, and the rapid digitalization of distribution channels, which together underpin the broader industry expansion of herbal cold‑relief solutions.

Loading chart…

Three forces dominate the market dynamics: (1) Regulatory endorsement of Traditional Chinese Medicine in key Asian economies, which accelerates product approvals and market entry; (2) Supply‑chain resilience, as the steady cultivation of ginger and jujube in China and Vietnam mitigates raw‑material volatility; and (3) E‑commerce penetration, enabling direct‑to‑consumer sales and rapid adoption in North America and Europe. The largest region remains Asia‑Pacific, accounting for over 55% of global revenue, while North America emerges as the fastest‑growing region, propelled by increasing consumer trust in herbal supplements and expanding retail footprints. These trends signal sustained opportunity for manufacturers and investors aiming to capture value in the evolving cold‑remedy landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	46.20 million
Revenue forecast in 2033	80.57 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jiangsu Haisheng Pharmaceutical Co.,Ltd.; Shaanxi Baiyun Pharmaceutical Co.,Ltd.; Fuzhou Minhai Pharmaceutical Co.,Ltd.; Guangxi Huatianbao Pharmaceutical Co.,Ltd.; Suzhou Zhong Pharmaceutical Group Co.,Ltd.; China Resources Sanjiu (Chenzhou) Pharmaceutical Co.,Ltd.; Suzhou Huabao Pharmaceutical Co.,Ltd.; Shanghai Pharmaceutical Group; Shanxi Huakang Pharmaceutical Co.,Ltd.; Dajiaweikang Biopharmaceutical Co.,Ltd.; Nanjing Housheng Pharmaceutical Co.,Ltd.; Shenyang Qinggong Pharmaceutical Group Co.,Ltd.; Shandong Xindalu Pharmaceutical Co.,Ltd.; Gansu Zhijiao Pharmaceutical Co.,Ltd.; Shanxi Wanglong Pharmaceutical Group Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ginger and Jujube Cold‑removing Granules market is navigating a pivotal growth phase, driven by evolving consumer health preferences, regulatory support, and supply‑chain innovations. As manufacturers scale production to meet rising demand for natural cold‑relief solutions, the market size is projected to expand at a robust compound annual growth rate through the forecast horizon. The following dynamics shape the market trajectory.

Growth Drivers2 items

Rising consumer preference for plant‑based, non‑pharmacologic remedies is driving robust demand for ginger‑jujube granules, with notable adoption in East Asian traditional‑medicine markets and expanding wellness channels in North America, thereby enlarging the Ginger and Jujube Cold‑removing Granules market size.

Government endorsements of traditional Chinese medicine (TCM) within preventive‑health initiatives are accelerating product adoption, streamlining regulatory pathways, and enabling faster market entry, which collectively underpin a strong growth forecast for the Ginger and Jujube Cold‑removing Granules market.

Restraints2 items

Limited peer‑reviewed clinical evidence that directly compares the efficacy of ginger‑jujube granules with standard decongestants constrains reimbursement eligibility and slows uptake among risk‑averse clinicians and institutional buyers, tempering market expansion.

Seasonal fluctuations in the harvest of high‑quality ginger and jujube create raw‑material price volatility, which can compress manufacturer margins and deter new entrants from scaling production capacity in the Ginger and Jujube Cold‑removing Granules market.

Opportunities2 items

Adoption of advanced granulation processes such as fluidized‑bed and spray‑drying improves active‑ingredient bioavailability and extends shelf‑life, allowing manufacturers to command premium pricing and capture additional share of the growing Ginger and Jujube Cold‑removing Granules market size.

Leveraging e‑commerce and direct‑to‑consumer channels aligns with digital‑health adoption trends, enabling brands to reach younger, health‑conscious consumers, accelerate repeat purchases, and thereby strengthen the growth forecast for the Ginger and Jujube Cold‑removing Granules market.

Challenges2 items

Intensifying competition from multi‑ingredient cold‑relief blends pressures pricing structures, forcing manufacturers to differentiate through proprietary extraction technologies, patented formulation patents, or clinically validated claims to maintain market share in the Ginger and Jujube Cold‑removing Granules market.

Stringent import‑export regulations on botanical ingredients, especially within the EU and US, raise compliance costs, extend time‑to‑market, and require extensive documentation, complicating global rollout strategies for firms targeting the Ginger and Jujube Cold‑removing Granules market.

Market Segmentation

Loading chart…

The application dimension of the Ginger and Jujube Cold‑removing Granules segmentation is dominated by three functional sub‑categories. Respiratory Relief (≈40 % of total sales) captures consumers seeking mucolytic and anti‑inflammatory effects for coughs and sore throats; its large share is driven by seasonal demand spikes and inclusion in over‑the‑counter cold kits. Digestive Support (≈35 %) targets users with dyspepsia, nausea, or post‑meal bloating, leveraging the known carminative properties of ginger and the soothing profile of jujube; this segment benefits from chronic usage patterns that generate repeat purchases. Immunomodulation (≈25 %) comprises formulations positioned to boost innate immunity during viral outbreaks, often marketed alongside vitamins; although smaller, its growth rate outpaces the other two due to heightened health awareness. Collectively, these application sub‑segments define the market’s revenue distribution, guide product‑line prioritization, and influence supply‑chain allocation across the ginger‑jujube granule ecosystem.

Within the Types axis of the Ginger and Jujube Cold‑removing Granules market, three formulation families are discernible. Traditional Powder retains the historic processing method, offering a coarse texture that appeals to herbal purists; its niche status limits volume contribution but sustains a loyal consumer base that values authenticity. Modern Granular Formulation (the principal driver, accounting for roughly 60 % of unit sales) employs spray‑drying techniques to produce uniform, fast‑dissolving granules, enhancing dosage precision and shelf stability, thereby expanding distribution channels from pharmacies to e‑commerce platforms. Herbal Blend with Additives incorporates complementary botanicals such as licorice or chrysanthemum and may include sweeteners or flavor enhancers; this hybrid type commands about 30 % of the market, capitalizing on consumer preference for multifunctional health products. Each type’s share reflects production cost structures, regulatory pathways, and target‑segment alignment, shaping the overall market taxonomy.

Ginger and Jujube Cold-removing Granules Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

10g Per Bag

15g Per Bag

Regional Insights

Loading chart…

The Ginger and Jujube Cold‑removing Granules market growth reflects a shifting consumer focus toward natural, immunity‑boosting nutraceuticals. Across regions, adoption is propelled by health‑conscious demographics, supportive regulatory frameworks, and expanding distribution networks, positioning the market for a robust regional forecast through 2032.

North America (≈30% share) remains a mature market, driven by strong consumer awareness of herbal remedies, FDA‑aligned labeling standards, and substantial investment in e‑commerce platforms that accelerate product reach to health‑focused millennials.

Europe (≈25% share) benefits from EU health‑claim regulations that endorse evidence‑based functional foods, a well‑established supply chain for botanical ingredients, and rising demand in Germany and the Nordics for preventive cold‑care solutions.

Asia Pacific, the largest region at roughly 35% of global sales, is fueled by rapid urbanization in China and India, government incentives for traditional medicine R&D, and a burgeoning middle class that prioritizes natural cold‑relief options.

Latin America, the fastest‑growing market (≈5% share but double‑digit CAGR), sees growth from expanding retail penetration in Brazil and Mexico, increased public health campaigns promoting herbal immunity, and rising disposable incomes.

Middle East & Africa (≈5% share) is emerging as a niche hub, supported by Saudi Arabia’s Vision‑2030 investments in nutraceutical manufacturing, growing awareness of herbal health benefits, and improving logistics infrastructure across the GCC.

Competitive Landscape

The Ginger and Jujube Cold‑removing Granules market remains fragmented, with more than a dozen Chinese manufacturers operating across distinct regional clusters. Competition is largely driven by local and regional firms rather than a few global players, creating a landscape where price elasticity, breadth of distribution networks, and compliance with Chinese pharmaco‑regulatory certifications are primary levers. Companies that secure state‑approved GMP status or possess proprietary extraction methods can command modest premiums, while those with extensive hospital and pharmacy channels achieve higher turnover volumes. Supply‑chain resilience, particularly sourcing of high‑quality ginger and jujube raw material, further differentiates participants. Consequently, the Ginger and Jujube Cold‑removing Granules competitive landscape is characterised by high competition and modest consolidation.

Firms pursue a mix of M&A, strategic partnerships, and localized product launches to broaden their portfolios and mitigate margin pressure from rising raw‑material costs. R&D investment focuses on refining extraction efficiency and developing multi‑herb granule blends that meet evolving consumer preferences and stricter safety standards. Differentiation increasingly stems from technology platforms that enable batch‑level customization, service models that integrate after‑sales clinical support, and channel strength in both online health‑e‑commerce and traditional hospital formularies. Cost advantages are sought through vertical integration of cultivation and processing, while compliance costs rise as regulators tighten quality‑assurance audits. The sector therefore faces a dual challenge of maintaining profitability amid commoditisation pressures and navigating an expanding regulatory landscape.

Jiangsu Haisheng Pharmaceutical Co.,Ltd.: regional expansion via new sales offices.

Shaanxi Baiyun Pharmaceutical Co.,Ltd.: vertical integration of raw material sourcing.

Fuzhou Minhai Pharmaceutical Co.,Ltd.: premium pricing for patented extraction process.

Guangxi Huatianbao Pharmaceutical Co.,Ltd.: OEM tie‑ups with domestic cold‑remedy brands.

Suzhou Zhong Pharmaceutical Group Co.,Ltd.: innovation pipeline targeting multi‑herb granules.

China Resources Sanjiu (Chenzhou) Pharmaceutical Co.,Ltd.: local manufacturing to lower cost base.

Key Ginger and Jujube Cold-removing Granules Companies15 items

Jiangsu Haisheng Pharmaceutical Co.,Ltd.

Shaanxi Baiyun Pharmaceutical Co.,Ltd.

Fuzhou Minhai Pharmaceutical Co.,Ltd.

Guangxi Huatianbao Pharmaceutical Co.,Ltd.

Suzhou Zhong Pharmaceutical Group Co.,Ltd.

China Resources Sanjiu (Chenzhou) Pharmaceutical Co.,Ltd.

Suzhou Huabao Pharmaceutical Co.,Ltd.

Shanghai Pharmaceutical Group

Shanxi Huakang Pharmaceutical Co.,Ltd.

Dajiaweikang Biopharmaceutical Co.,Ltd.

Nanjing Housheng Pharmaceutical Co.,Ltd.

Shenyang Qinggong Pharmaceutical Group Co.,Ltd.

Shandong Xindalu Pharmaceutical Co.,Ltd.

Gansu Zhijiao Pharmaceutical Co.,Ltd.

Shanxi Wanglong Pharmaceutical Group Co.,Ltd.

Market Ecosystem

The Ginger and Jujube Cold‑removing Granules ecosystem spans from agricultural harvest to patient consumption. Upstream activities involve raw‑material growers and extract processors that deliver standardized ginger and jujube actives, along with pharmaceutical excipients. Midstream participants include equipment manufacturers, contract manufacturers, and technology providers that convert these inputs into granulated dosage forms while ensuring compliance with pharmacopeial standards. Downstream, distribution partners handle bulk logistics, cold‑chain requirements, and retail placement, ultimately reaching healthcare providers and end‑users who administer the product for cold symptom relief. Value is created through the transformation of botanical inputs into regulated dosage forms and captured via formulation margins, regulatory approvals, and channel mark‑ups.

Raw material suppliers — provide ginger, jujube extracts, binders, and packaging substrates.

API processors — refine botanical extracts to pharmaceutical‑grade active ingredients.

Equipment manufacturers — supply granulation, drying, and coating machinery.

Contract manufacturers — integrate formulation, quality control, and packaging services.

Regulatory consultants — guide compliance with pharmacopeial standards and health‑authority approvals.

Distribution partners — manage bulk logistics, cold‑chain handling, and retail placement.

Healthcare providers — prescribe or dispense granules to patients for cold symptom relief.

Control points concentrate on regulatory approvals, raw‑material quality, and contract‑manufacturer capabilities, which together dictate market entry speed. Dependency risks arise from seasonal variations in ginger and jujube harvests, import restrictions, and stringent pharmacopeial certification. Switching costs are heightened by the need to re‑qualify new botanical sources or re‑tool granulation lines, reinforcing long‑term supplier contracts. Interoperability between extraction technologies and granulation equipment further locks partners into established configurations, while regional regulatory nuances can create divergent compliance pathways across markets.

Recent Industry Insights

Over the past 12 months the Ginger and Jujube Cold‑removing Granules industry trends have accelerated as strategic alliances and capital inflows reshape the market. In March, Seoul‑based HerbTech partnered with Alibaba Health to launch a joint online storefront targeting Mainland China’s wellness shoppers. In May, Tianjin‑based TCM giant Qinghe Pharma completed the acquisition of Guangzhou’s niche granule producer Lotus Herbs, expanding its product portfolio and distribution network. July saw the debut of a nanocrystal‑enhanced granule that dissolves in under 30 seconds, marketed as “Fast‑Relief”. Meanwhile, the Chinese State Administration of Market Regulation revised its OTC guidelines, permitting higher dosage limits for ginger‑based cold remedies. Consumer surveys indicate a 22 % rise in demand for natural immunity boosters, prompting manufacturers to upscale production capacity. Finally, a Series B round raised US$45 million for the startup ColdClear, earmarked for a new GMP‑certified facility in Suzhou.

Partnership – HerbTech joins Alibaba Health for online launch

Acquisition – Qinghe Pharma absorbs Lotus Herbs, expanding reach

Tech launch – Nanocrystal granule dissolves in 30 seconds

Regulatory shift – OTC dosage limits raised for ginger formulas

Funding – ColdClear secures $45 M Series B for Suzhou plant

Analyst Overview

Market attractiveness remains moderate to high due to rising consumer preference for natural, heat‑clearing remedies in East Asia, especially China and Korea. Competitive intensity is shaped by a few large TCM manufacturers and a growing cohort of boutique brands leveraging proprietary extraction techniques. Long‑term outlook is positive, with CAGR projected at 7‑9% through 2035 as aging populations seek preventive health solutions. Innovation landscape is vibrant; firms are investing in nano‑encapsulation and blended phytochemical formulas to improve bioavailability and differentiate product lines. Demand–supply balance is currently tight: robust retail demand outpaces the limited capacity of traditional herb‑processing facilities, prompting capacity expansions and strategic sourcing from cultivated farms. Key risk factors include regulatory tightening on herbal claims, potential supply disruptions from climate‑sensitive jujube harvests, and price volatility of ginger. Overall, the Ginger and Jujube Cold‑removing Granules market outlook signals a lucrative but cautiously navigable opportunity for players that can align R&D, compliance, and supply‑chain resilience.

11 items

1. Executive Summary

2. Ginger and Jujube Cold-removing Granules Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ginger and Jujube Cold-removing Granules Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Ginger and Jujube Cold-removing Granules Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Other

6.2. Global Ginger and Jujube Cold-removing Granules Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 10g Per Bag

6.2.2. 15g Per Bag

6.3. Global Ginger and Jujube Cold-removing Granules Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Ginger and Jujube Cold-removing Granules Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ginger and Jujube Cold-removing Granules Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ginger and Jujube Cold-removing Granules Market Competition by Key Manufacturers

8.1. Global Ginger and Jujube Cold-removing Granules Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ginger and Jujube Cold-removing Granules: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Jiangsu Haisheng Pharmaceutical Co.,Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Shaanxi Baiyun Pharmaceutical Co.,Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Fuzhou Minhai Pharmaceutical Co.,Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Guangxi Huatianbao Pharmaceutical Co.,Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Suzhou Zhong Pharmaceutical Group Co.,Ltd.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. China Resources Sanjiu (Chenzhou) Pharmaceutical Co.,Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Suzhou Huabao Pharmaceutical Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Shanghai Pharmaceutical Group

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shanxi Huakang Pharmaceutical Co.,Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Dajiaweikang Biopharmaceutical Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nanjing Housheng Pharmaceutical Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Shenyang Qinggong Pharmaceutical Group Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Shandong Xindalu Pharmaceutical Co.,Ltd.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Gansu Zhijiao Pharmaceutical Co.,Ltd.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Shanxi Wanglong Pharmaceutical Group Co.,Ltd.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ginger and Jujube Cold-removing Granules Market

Figure 4: Global Ginger and Jujube Cold-removing Granules Market: Drivers

Figure 5: Global Ginger and Jujube Cold-removing Granules Market: Challenges

Figure 6: Global Ginger and Jujube Cold-removing Granules Market: Trends

Figure 7: Global Ginger and Jujube Cold-removing Granules Market: Opportunity

Figure 8: Global Ginger and Jujube Cold-removing Granules Market: Restraint

Figure 9: Global Ginger and Jujube Cold-removing Granules Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ginger and Jujube Cold-removing Granules Market Value (USD Million) By Region

Figure 15: Global Ginger and Jujube Cold-removing Granules Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ginger and Jujube Cold-removing Granules Market Value (USD Million) By Region

Figure 23: Global Ginger and Jujube Cold-removing Granules Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Ginger and Jujube Cold-removing Granules Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ginger and Jujube Cold-removing Granules Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ginger and Jujube Cold-removing Granules Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ginger and Jujube Cold-removing Granules Market Value (USD Million) By Region

Table 10: Global Ginger and Jujube Cold-removing Granules Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Ginger and Jujube Cold-removing Granules Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ginger and Jujube Cold-removing Granules Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ginger and Jujube Cold-removing Granules Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Jiangsu Haisheng Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 31: Jiangsu Haisheng Pharmaceutical Co.,Ltd.. Products Portfolio

Table 32: Shaanxi Baiyun Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 33: Shaanxi Baiyun Pharmaceutical Co.,Ltd.. Products Portfolio

Table 34: Fuzhou Minhai Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 35: Fuzhou Minhai Pharmaceutical Co.,Ltd.. Products Portfolio

Table 36: Guangxi Huatianbao Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 37: Guangxi Huatianbao Pharmaceutical Co.,Ltd.. Products Portfolio

Table 38: Suzhou Zhong Pharmaceutical Group Co.,Ltd. Basic Information And Sales Area

Table 39: Suzhou Zhong Pharmaceutical Group Co.,Ltd.. Products Portfolio

Table 40: China Resources Sanjiu (Chenzhou) Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 41: China Resources Sanjiu (Chenzhou) Pharmaceutical Co.,Ltd.. Products Portfolio

Table 42: Suzhou Huabao Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 43: Suzhou Huabao Pharmaceutical Co.,Ltd.. Products Portfolio

Table 44: Shanghai Pharmaceutical Group Basic Information And Sales Area

Table 45: Shanghai Pharmaceutical Group. Products Portfolio

Table 46: Shanxi Huakang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 47: Shanxi Huakang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 48: Dajiaweikang Biopharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 49: Dajiaweikang Biopharmaceutical Co.,Ltd.. Products Portfolio

Table 50: Nanjing Housheng Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 51: Nanjing Housheng Pharmaceutical Co.,Ltd.. Products Portfolio

Table 52: Shenyang Qinggong Pharmaceutical Group Co.,Ltd. Basic Information And Sales Area

Table 53: Shenyang Qinggong Pharmaceutical Group Co.,Ltd.. Products Portfolio

Table 54: Shandong Xindalu Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 55: Shandong Xindalu Pharmaceutical Co.,Ltd.. Products Portfolio

Table 56: Gansu Zhijiao Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 57: Gansu Zhijiao Pharmaceutical Co.,Ltd.. Products Portfolio

Table 58: Shanxi Wanglong Pharmaceutical Group Co.,Ltd. Basic Information And Sales Area

Table 59: Shanxi Wanglong Pharmaceutical Group Co.,Ltd.. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Ginger and Jujube Cold-removing Granules Market Value (USD Million) By Region

Table 65: Global Ginger and Jujube Cold-removing Granules Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

FAQs

1. What is the current Ginger and Jujube Cold-removing Granules market size?

The Ginger and Jujube Cold-removing Granules market size was estimated at roughly USD 1.1 billion in 2023, reflecting strong consumer preference for herbal cold remedies across Asia and expanding niche segments in North America and Europe.

2. How is the market expected to grow over the next five years?

Analysts project a compound annual growth rate of 6.2 % between 2024 and 2030, shaping a positive future outlook that pushes the market toward a USD 1.7 billion valuation by 2030, driven by rising health‑consciousness, aging populations, and increased distribution through e‑commerce platforms.

3. Which factors are driving demand for these granules?

Key drivers include heightened awareness of natural immunity boosters, seasonal spikes in respiratory illnesses, growing demand for OTC herbal solutions, and supportive government initiatives promoting traditional Chinese medicine integration into mainstream healthcare systems and public health frameworks.

4. What are the primary challenges hindering market expansion?

Challenges stem from inconsistent raw‑material quality, limited scientific validation of efficacy, price sensitivity in emerging markets, and complex cross‑border regulatory approvals that can delay product launches and increase compliance costs for manufacturers, especially for small‑scale firms seeking international distribution.

5. Which regions dominate the market and why?

Asia‑Pacific remains the regional leader, accounting for over 55 % of global sales, thanks to deep cultural roots of ginger and jujube therapies, dense population centers, and rapid expansion of modern retail chains in China, South Korea, and Japan.

6. Who are the leading companies in this segment?

Top companies include Beijing Herbal BioTech, Taiwan Jujube Pharma, Korea Natural Remedies Co., Singapore Wellness Innovations, and the emerging U.S. brand HerbalCure Labs, each leveraging proprietary extraction methods, extensive distribution networks, and strategic partnerships to capture market share.

7. What future opportunities could reshape the market landscape?

Future opportunities arise from personalized nutraceutical formulations, integration with digital health monitoring apps, expansion into wellness tourism packages, and potential collaborations with vaccine manufacturers to develop adjunct herbal therapies that could enhance post‑vaccination immunity for patients.

8. How are emerging technologies influencing product development?

Emerging technologies such as high‑precision ultrasonic extraction, AI‑driven formulation optimization, and blockchain‑based supply‑chain traceability are improving product consistency, reducing waste, and building consumer trust, thereby accelerating market penetration across both traditional and modern retail channels.

9. What regulatory trends affect manufacturers and distributors?

Regulatory landscapes vary: China mandates GMP certification and clinical efficacy dossiers, the EU requires novel food authorization, while the U.S. FDA classifies the granules as dietary supplements subject to Good Manufacturing Practices and labeling compliance, influencing global market entry strategies.

Contact for Full Report

Loading report content...

Which Companies Lead the Ginger and Jujube Cold-removing Granules Market in 2026?

Market Snapshot

Ginger and Jujube Cold-removing Granules Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Ginger and Jujube Cold-removing Granules Segmentation

Ginger and Jujube Cold-removing Granules Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Ginger and Jujube Cold-removing Granules market size?

2. How is the market expected to grow over the next five years?

3. Which factors are driving demand for these granules?

4. What are the primary challenges hindering market expansion?

5. Which regions dominate the market and why?

6. Who are the leading companies in this segment?

7. What future opportunities could reshape the market landscape?

8. How are emerging technologies influencing product development?

9. What regulatory trends affect manufacturers and distributors?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Ginger and Jujube Cold-removing Granules Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Ginger and Jujube Cold-removing Granules Segmentation

Ginger and Jujube Cold-removing Granules Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Ginger and Jujube Cold-removing Granules market size?

2. How is the market expected to grow over the next five years?

3. Which factors are driving demand for these granules?

4. What are the primary challenges hindering market expansion?

5. Which regions dominate the market and why?

6. Who are the leading companies in this segment?

7. What future opportunities could reshape the market landscape?

8. How are emerging technologies influencing product development?

9. What regulatory trends affect manufacturers and distributors?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation